SynthesisFrontiers in immunology2026
First-line immune checkpoint inhibitors combined with targeted therapy for advanced renal cell carcinoma: a network meta-analysis and cost-effectiveness analysis.
Yize Jia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.